TMBR
Timber Pharmaceuticals, Inc.
TMBR
TMBR
Delisted
TMBR was delisted on the 28th of November, 2023.
17 hedge funds and large institutions have $2.64M invested in Timber Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
2 |
Citadel Advisors
Miami,
Florida
|
+$36K |
3 |
UBS Group
Zurich,
Switzerland
|
+$3K |
Top Sellers
1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59K |
2 |
Renaissance Technologies
New York
|
-$59K |
3 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
-$7K |
4 |
TSS
Two Sigma Securities
New York
|
-$5.33K |
5 |
VF
Virtu Financial
New York
|
-$5.33K |